Reproductive depression

References

• Dickens C. Household words. 1852;95:385–389.
   Google Scholar
• Studd J. A guide to hormone therapy for the treatment of depression in women. Climacteric 2011;14:637–642.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Tonani S, Santamaria V, Ornati A, Albani F, Pisani C, Polatti F. Luteal phase dysphoric disorder and premenstrual syndrome. It J Psych 2009;28:27–33.
   Google Scholar
• Panay N, Studd JW. The psychotherapeutic effects of estrogens. Gynecol Endocrinol 1998;12:353–365.
   PubMed Web of Science ®Google Scholar
• Stahl SM. Basic psychopharmacology of antidepressants, part 2: Estrogen as an adjunct to antidepressant treatment. J Clin Psychiatry 1998;59 Suppl 4:15–24.
   Google Scholar
• Wise PM, Dubal DB, Wilson ME, Rau SW, Liu Y. Estrogens: trophic and protective factors in the adult brain. Front Neuroendocrinol 2001;22:33–66.
   PubMed Web of Science ®Google Scholar
• McEwen BS, Alves SE. Estrogen actions in the central nervous system. Endocr Rev 1999;20:279–307.
   PubMed Web of Science ®Google Scholar
• Studd J, Panay N. Hormones and depression in women. Climacteric 2004;7:338–346.
   PubMed Web of Science ®Google Scholar
• Genazzani AR, Stomati M, Morittu A, Bernardi F, Monteleone P, Casarosa E, Gallo R, et al. Progesterone, progestagens and the central nervous system. Hum Reprod 2000;15 Suppl 1:14–27.
   Google Scholar
• McCarthy MM. Estradiol and the developing brain. Physiol Rev 2008;88:91–124.
   PubMed Web of Science ®Google Scholar
• Laflamme N, Nappi RE, Drolet G, Labrie C, Rivest S. Expression and neuropeptidergic characterization of estrogen receptors (ERalpha and ERbeta) throughout the rat brain: anatomical evidence of distinct roles of each subtype. J Neurobiol 1998;36:357–378.
   PubMedGoogle Scholar
• Weiser MJ, Foradori CD, Handa RJ. Estrogen receptor beta in the brain: from form to function. Brain Res Rev 2008;57:309–320.
   PubMed Web of Science ®Google Scholar
• Wise DD, Felker A, Stahl SM. Tailoring treatment of depression for women across the reproductive lifecycle: the importance of pregnancy, vasomotor symptoms, and other estrogen-related events in psychopharmacology. CNS Spectr 2008;13:647–662.
   Google Scholar
• McEwen BS, Alves SE, Bulloch K, Weiland NG. Ovarian steroids and the brain: implications for cognition and aging. Neurology 1997;48:S8–15.
   PubMed Web of Science ®Google Scholar
• Stahl SM. Natural estrogen as an antidepressant for women. J Clin Psychiatry 2001;62:404–405.
   Google Scholar
• Smith LJ, Henderson JA, Abell CW, Bethea CL. Effects of ovarian steroids and raloxifene on proteins that synthesize, transport, and degrade serotonin in the raphe region of macaques. Neuropsychopharmacology 2004;29:2035–2045.
   PubMed Web of Science ®Google Scholar
• Di Paolo T, Diagle M, Picard V, Barden N. Effect of acute and chronic 17 beta-estradiol treatment on serotonin and 5-hydroxyindole acetic acid content of discrete brain nuclei of ovariectomized rat. Exp Brain Res 1983;51:73–76.
   Google Scholar
• Kugaya A, Epperson CN, Zoghbi S, van Dyck CH, Hou Y, Fujita M, Staley JK, et al. Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry 2003;160:1522–1524.
   PubMed Web of Science ®Google Scholar
• Pau KY, Hess DL, Kohama S, Bao J, Pau CY, Spies HG. Oestrogen upregulates noradrenaline release in the mediobasal hypothalamus and tyrosine hydroxylase gene expression in the brainstem of ovariectomized rhesus macaques. J Neuroendocrinol 2000;12:899–909.
   PubMed Web of Science ®Google Scholar
• Vetrivelan R, Mallick HN, Kumar VM. Tonic activity of alpha1 adrenergic receptors of the medial preoptic area contributes towards increased sleep in rats. Neuroscience 2006;139:1141–1151.
   Google Scholar
• Thompson TL, Moss RL. Modulation of mesolimbic dopaminergic activity over the rat estrous cycle. Neurosci Lett 1997;229:145–148.
   PubMed Web of Science ®Google Scholar
• Cheng CM, Cohen M, Wang J, Bondy CA. Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex. FASEB J 2001;15:907–915.
   PubMed Web of Science ®Google Scholar
• Shi J, Simpkins JW. 17 beta-Estradiol modulation of glucose transporter 1 expression in blood-brain barrier. Am J Physiol 1997;272:E1016–E1022.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Rivest S. Ovulatory cycle influences the stimulatory effect of stress on the expression of corticotropin-releasing factor receptor messenger ribonucleic acid in the paraventricular nucleus of the female rat hypothalamus. Endocrinology 1995;136:4073–4083.
   PubMed Web of Science ®Google Scholar
• Tahboub R, Arafah BM. Sex steroids and the thyroid. Best Pract Res Clin Endocrinol Metab 2009;23:769–780.
   Web of Science ®Google Scholar
• Studd J. Why are estrogens rarely used for the treatment of depression in women? Gynecol Endocrinol 2007;23:63–64.
   PubMed Web of Science ®Google Scholar
• Burger HG, Hale GE, Robertson DM, Dennerstein L. A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women’s Midlife Health Project. Hum Reprod Update 2007;13:559–565.
   PubMed Web of Science ®Google Scholar
• Studd J. Ovarian cycle syndrome. Gynecol Endocrinol 2009;25:74.
   PubMed Web of Science ®Google Scholar
• Rapkin AJ. YAZ in the treatment of premenstrual dysphoric disorder. J Reprod Med 2008;53:729–741.
   PubMed Web of Science ®Google Scholar
• Panay N, Studd J. Progestogen intolerance and compliance with hormone replacement therapy in menopausal women. Hum Reprod Update 1997;3:159–171.
   PubMed Web of Science ®Google Scholar
• Watson NR, Studd JW, Savvas M, Garnett T, Baber RJ. Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone. Lancet 1989;2:730–732.
   PubMed Web of Science ®Google Scholar
• Elovainio M, Teperi J, Aalto AM, Grenman S, Kivelä A, Kujansuu E, Vuorma S, et al. Depressive symptoms as predictors of discontinuation of treatment of menorrhagia by levonorgestrel-releasing intrauterine system. Int J Behav Med 2007;14:70–75.
   PubMed Web of Science ®Google Scholar
• Leather AT, Studd JW, Watson NR, Holland EF. The prevention of bone loss in young women treated with GnRH analogues with “add-back” estrogen therapy. Obstet Gynecol 1993;81:104–107.
   PubMed Web of Science ®Google Scholar
• Wyatt KM, Dimmock PW, Ismail KM, Jones PW, O’Brien PM. The effectiveness of GnRHa with and without ‘add-back’ therapy in treating premenstrual syndrome: a meta analysis. BJOG 2004;111:585–593.
   PubMed Web of Science ®Google Scholar
• Leather AT, Studd JW, Watson NR, Holland EF. The treatment of severe premenstrual syndrome with goserelin with and without ‘add-back’ estrogen therapy: a placebo-controlled study. Gynecol Endocrinol 1999;13:48–55.
   PubMed Web of Science ®Google Scholar
• Di Carlo C, Palomba S, Tommaselli GA, et al. Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome. Fertil Steril 2001;76:850–852.
   PubMedGoogle Scholar
• Casson P, Hahn PM, Van Vugt DA, Reid RL. Lasting response to ovariectomy in severe intractable premenstrual syndrome. Am J Obstet Gynecol 1990;162:99–105.
   PubMed Web of Science ®Google Scholar
• Cronje WH, Vashisht A, Studd JW. Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome. Hum Reprod 2004;19:2152–2155.
   PubMed Web of Science ®Google Scholar
• Studd J. Spotlight on severe premenstrual syndrome and bipolar disorder: a frequent tragic confusion. Climacteric 2011;14:602.
   PubMed Web of Science ®Google Scholar
• Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 2000;157:924–930.
   PubMed Web of Science ®Google Scholar
• Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 1996;347:930–933.
   PubMed Web of Science ®Google Scholar
• Dennis CL, Ross LE, Herxheimer A. Oestrogens and progestins for preventing and treating postpartum depression. Cochrane Database Syst Rev 2008;4:CD001690.
   Google Scholar
• Dennerstein L, Lehert P, Burger H, Dudley E. Mood and the menopausal transition. J Nerv Ment Dis 1999;187:685–691.
   PubMed Web of Science ®Google Scholar
• Brincat M, Magos A, Studd JW, Cardozo LD, O’Dowd T, Wardle PJ, Cooper D. Subcutaneous hormone implants for the control of climacteric symptoms. A prospective study. Lancet 1984;1:16–18.
   PubMed Web of Science ®Google Scholar
• Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001;58:529–534.
   PubMed Web of Science ®Google Scholar
• Montgomery JC, Appleby L, Brincat M, Versi E, Tapp A, Fenwick PB, Studd JW. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet 1987;1:297–299.
   PubMed Web of Science ®Google Scholar
• Graziottin A, Serafini A. Depression and the menopause: why antidepressants are not enough? Menopause Int 2009;15:76–81.
   PubMedGoogle Scholar